Journal of Biological Chemistry · 2004 · 344 citations · 55 references
Intracellular Calcium LevelsRenal PathologyIntracellular Calcium MobilizationCalcium RestrictionCellular PhysiologyRenal FunctionSignaling PathwayCell RegulationReceptor Tyrosine KinaseCellular Regulatory MechanismChronic Kidney DiseaseCell SignalingB-raf/erk PathwayCell PhysiologyMolecular SignalingMolecular PhysiologyCamp-dependent Growth-stimulated PhenotypeRenal PathophysiologyCell BiologyUrologySignal TransductionDevelopmental BiologyPhysiologyMedicineNephrologyKidney Research
cAMP can be either mitogenic or anti-mitogenic, depending on the cell type. We demonstrated previously that cAMP inhibited the proliferation of normal renal epithelial cells and stimulated the proliferation of cells derived from the cysts of polycystic kidney disease (PKD) patients. The protein products of the genes causing PKD, polycystin-1 and polycystin-2, are thought to regulate intracellular calcium levels, suggesting that abnormal polycystin function may affect calcium signaling and thus cause a switch to the cAMP growth-stimulated phenotype. To test this hypothesis, we disrupted intracellular calcium mobilization by treating immortalized mouse M-1 collecting duct cells and primary cultures of human kidney epithelial cells with calcium channel blockers and by lowering extracellular calcium with EGTA. Calcium restriction for 3-5 h converted both cell types from a normal cAMP growth-inhibited phenotype to an abnormal cAMP growth-stimulated phenotype, characteristic of PKD. In M-1 cells, we showed that calcium restriction was associated with an elevation in B-Raf protein levels and cAMP-stimulated, Ras-dependent activation of B-Raf and ERK. Moreover, the activity of Akt, a negative regulator of B-Raf, was decreased by calcium restriction. Inhibition of Akt or phosphatidylinositol 3-kinase also allowed cAMP-dependent activation of B-Raf and ERK in normal calcium. These results suggest that calcium restriction causes an inhibition of the phosphatidylinositol 3-kinase/Akt pathway, which relieves the inhibition of B-Raf to allow the cAMP growth-stimulated phenotypic switch. Finally, M-1 cells stably overexpressing an inducible polycystin-1 C-terminal cytosolic tail construct were shown to exhibit a cAMP growth-stimulated phenotype involving B-Raf and ERK activation, which was reversed by the calcium ionophore A23187. We conclude that disruption of calcium mobilization in cells that are normally growth-inhibited by cAMP can derepress the B-Raf/ERK pathway, thus converting these cells to a phenotype that is growth-stimulated by cAMP.
55
BRAF and RAS mutations in human lung cancer and melanoma.
Marcia S. Brose, Patrícia Volpe, Michael D. Feldman et al. · PubMed · 2002 · 1K citations
Complexes of Ras⋅GTP with Raf-1 and Mitogen-Activated Protein Kinase Kinase
Shonna A. Moodie, Berthe M. Willumsen, Michael J. Weber et al. · Science · 1993 · 980 citations
Inhibition of the EGF-Activated MAP Kinase Signaling Pathway by Adenosine 3′,5′-Monophosphate
Jie Wu, Paul Dent, Tomáš Jelı́nek et al. · Science · 1993 · 937 citations
Co-assembly of polycystin-1 and -2 produces unique cation-permeable currents
Kazushige Hanaoka, Feng Qian, Alessandra Boletta et al. · Nature · 2000 · 808 citations